Rebecca Araujo

Articles by Rebecca Araujo

Rebecca AraujoPsoriatic Arthritis | April 19, 2024
A study assessed deucravacitinib in patients with active psoriatic arthritis compared with placebo.
Read More
Rebecca AraujoPsoriatic Arthritis | April 17, 2024
Patients with psoriatic arthritis who have enthesitis are more likely to persist on treatment with tofacitinib.
Rebecca AraujoDepression | April 17, 2024
A family history of treatment-resistant depression is a risk factor for resistance to antidepressants.
Rebecca AraujoHOPA Annual Conference 2024 | April 9, 2024
Patients with a history of venous thromboembolism were more likely to receive VTE prophylaxis.
Rebecca AraujoHOPA Annual Conference 2024 | April 9, 2024
Patients ≥70 years of age were more likely to have a reduction in their palbociclib dosage.
Rebecca AraujoHOPA Annual Conference 2024 | April 9, 2024
Rates of treatment-related hypersensitivity reactions were low in an academic community setting.
Rebecca AraujoHOPA Annual Conference 2024 | April 9, 2024
Same-day administration of pegfilgrastim was not linked to a greater incidence of grade ≥3 neutropenia.
Rebecca AraujoHOPA Annual Conference 2024 | April 8, 2024
Lenvatinib plus pembrolizumab led to a clinically relevant response in patients with baseline metastasis.
Rebecca AraujoHOPA Annual Conference 2024 | April 8, 2024
Higher average talazoparib concentrations were associated with an increased risk of severe anemia and thrombocytopenia.
Rebecca AraujoHOPA Annual Conference 2024 | April 8, 2024
Decreasing the at-home dose of dexamethasone before paclitaxel treatment may help reduce the incidence of infusion reactions.
Rebecca AraujoHOPA Annual Conference 2024 | April 8, 2024
Protected administrative time was ranked as the most important change to improve well-being.
Rebecca AraujoHOPA Annual Conference 2024 | April 3, 2024
Ibrutinib dose reductions were associated with fewer recurrent cardiac adverse events in patients with B-cell malignancies.
Rebecca AraujoHOPA Annual Conference 2024 | April 3, 2024
The REMEDY trial evaluated remote continuous temperature monitoring in patients receiving cytotoxic chemotherapy.
Rebecca AraujoHOPA Annual Conference 2024 | April 3, 2024
PTCy/Tac/MMF and tacrolimus plus methotrexate provided similar rates of graft-versus-host disease prevention.
Rebecca AraujoHOPA Annual Conference 2024 | April 3, 2024
Cemiplimab plus chemotherapy as a first-line treatment for advanced NSCLC led to improved survival.
Rebecca AraujoPsoriatic Arthritis | April 2, 2024
Treatment with guselkumab provided a durable therapeutic benefit to patients with psoriatic arthritis.
Rebecca AraujoRheumatology | March 25, 2024
Reproductive health outcomes appear to be greatly impacted by the presence of rheumatic diseases.
Rebecca AraujoMental Health | March 21, 2024
Patients with self-reported mental health disorders demonstrated a low frequency of oral hygiene behaviors.
Rebecca AraujoOsteoarthritis | March 19, 2024
Between 1990 and 2019, the global incidence of early-onset osteoarthritis doubled.
Rebecca AraujoDepression | March 19, 2024
For children/adolescents with obesity, physical activity was strongly associated with improvement in anxiety and depression.